meta_pixel
Tapesearch Logo
Real Life Pharmacology - Pharmacology Education for Health Care Professionals

Top 200 Drugs – Medications 166-170

Real Life Pharmacology - Pharmacology Education for Health Care Professionals

Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist

Education, Health & Fitness, Medicine

5716 Ratings

🗓️ 23 January 2025

⏱️ 25 minutes

🧾️ Download transcript

Summary

Today’s sponsor is Freed AI! Freed’s AI medical scribe listens, transcribes, and writes notes for you. Over 15,000 healthcare professionals use Freed and you should too! Learn more here!



On this episode of the Top 200 Drugs podcast from Real Life Pharmacology, we cover Percocet, Epogen, quetiapine, glimepiride, and tirzepatide. These are drugs 166-170.



Percocet is a combination analgesic. It contains acetaminophen and oxycodone. Pay attention to acetaminophen intake from all sources when patients are on this medication.



Epogen (epoetin alfa) stimulates the production of red blood cells. This medication can be useful in treating anemia.



Quetiapine (Seroquel) is an antipsychotic. It is often used in patients with hallucinations and delusions associated with Parkinson's disease because it has a lower potential to block dopamine receptors compared to other antipsychotics.



Glimepiride is a sulfonylurea. This medication stimulates the release of insulin which can help lower blood sugars in diabetes.



Tirzepatide (Mounjaro) is a combination GIP and GLP-1 receptor agonist that can be used for weight loss and the treatment of diabetes.

Transcript

Click on a timestamp to play from that location

0:00.0

Hey, healthcare friends. Do you dread doing your notes every day? Do you feel like you can never get ahead of charting?

0:07.1

If you're shaking your head, yes, keep listening. Freed AI is a medical scribe on a mission to free clinicians everywhere.

0:15.8

Freed AI listens, transcribes, and writes medical documentation for you, written in your style,

0:22.6

and ready the moment the visit is over. All you have to do is give it to your patient. Just imagine

0:28.3

leaving the office at the same time as your last patient. Freed is HIPAA compliant, secure, and

0:35.2

takes less than 30 seconds to learn.

0:42.6

Artificial intelligence cannot replace you, but it can do the administrative work that no human should be subjected to.

0:45.0

Get back to doing what you love, helping your patients, and let freed AI do the rest.

0:50.7

Hey, all, welcome back to the real-life pharmacology podcast.

0:53.8

I'm your host pharmacist, Eric

0:55.0

Christensen. Thank you so much for listening today. As always, go check out the Real Life

1:00.9

Pharmacology Top 200 study guide. It's a 31-page PDF, great refresher on things that show up on

1:08.0

board exams, as well as common things you'll see in practice.

1:12.1

So simply an email, we'll get you access to that

1:14.5

at real-life pharmacology.com.

1:17.0

All right, let's get into the drugs of the day today,

1:20.1

and that is 166 through 170.

1:22.9

First one we have is oxycodone, acetaminopin combination.

1:26.9

Brand name is Percocette. I see it most commonly

1:30.7

used for post-op pain, that type of thing, but can be used for various pain syndromes.

1:37.7

Mechanistically, acetaminophen, I think I've covered that in the past. Oxxycodone is a full opioid agonist.

1:46.4

So it's got that activity by stimulating mu receptors in the central nervous system,

...

Transcript will be available on the free plan in -64 days. Upgrade to see the full transcript now.

Disclaimer: The podcast and artwork embedded on this page are from Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.